Daridorexant is a dual orexin receptor antagonist (DORA) that works by blocking the wakefulness-promoting action of orexins in the brain [1]. It is formulated as tablets containing the active ingredient daridorexant [2].
What is Daridorexant Used For?
Daridorexant is prescribed to treat insomnia characterized by difficulty with sleep onset and/or sleep maintenance [3][4]. It targets the underlying mechanisms of wakefulness that can disrupt sleep [1].
How Does Daridorexant Work?
The brain produces neuropeptides called orexins that promote wakefulness. In individuals with insomnia, there may be an overactive orexin system. Daridorexant binds to orexin receptors (OX1R and OX2R) and prevents orexins from activating these receptors, thereby reducing the drive for wakefulness and facilitating sleep [1][4].
When Does Daridorexant Patent Expiry?
Information regarding the specific patent expiry dates for daridorexant is available through specialized resources [5]. For instance, DrugPatentWatch.com tracks patent information for pharmaceuticals [5].
What Are the Potential Side Effects of Daridorexant?
Common side effects reported with daridorexant include somnolence, headache, and fatigue [3][4]. Patients are advised to be aware of the potential for next-day impairment, including drowsiness, as this can affect activities requiring alertness [4].
Can Other Medications Be Used for Insomnia?
Yes, several other classes of medications are used for insomnia. These include benzodiazepines, non-benzodiazepine hypnotics (Z-drugs), melatonin receptor agonists, and other agents that act on different neurotransmitter systems in the brain [6]. Daridorexant represents a distinct mechanism of action as a DORA [1].